出版：MarketsandMarkets（マーケッツアンドマーケッツ） 出版年月：2024年2月
Medical Nitrous Oxide Market – Global Forecasts to 2029
医療用亜酸化窒素市場 : 製品（気体、液体）、用途（麻酔、疼痛、凍結手術、外科的注入）、エンドユーザー（病院、在宅医療、学術機関、研究機関）、主要ステークホルダーと購入基準 – 2029年までの世界予測
Medical Nitrous Oxide Market by Product (Gas, Liquid), Application (Anaesthesia, Pain, Cryosurgery, Surgical Insufflation), End User (Hospital, Home healthcare, Academic, Research Institution), Key Stakeholder & Buying Criteria – Global Forecast to 2029
| ページ数 | 202 |
| 図表数 | 229 |
| 種別 | 英文調査報告書 |
| 価格 |
Report Overview
The global medical nitrous oxide market size is estimated to be USD 2.8 billion by 2029, from USD 1.8 billion in 2023, at a CAGR of 6.6%.
世界の医療用亜酸化窒素市場規模は、CAGR 6.6%で、2023年の18億ドルから2029年までに28億ドルに達すると推定されています。
The expansion of the medical nitrous oxide market is primarily fueled by various factors, including the increasing elderly population, advancements in healthcare infrastructure, a desire for non-invasive pain relief methods, and the existence of supportive regulations governing medical gas usage. Furthermore, the surge in surgical procedures, evident in both developed and developing nations, creates a favorable opportunity for the heightened utilization of medical nitrous oxide in anesthesia and analgesia, paving the way for additional growth prospects in the industry.
“The gasesous segment is expected to account for the largest market share in 2023.”
The medical nitrous oxide market is segmented based on product into gaseous and liquid states. As of 2023, the gaseous segment dominated the market. The prevalence of the gaseous state in the medical nitrous oxide market is attributed to its versatility in applications, particularly in anesthesia and analgesia during surgical procedures. The preference for the gaseous form in medical environments is driven by its ease of administration, precise dosage control, and rapid onset of action.
“The anesthesia and pain relief segment to register the highest growth rate in the forecast period.”
The medical nitrous oxide market, by application is segmented into anesthesia and pain relief, cryosurgery, and surgical insufflation. As of 2023, the anesthesia and pain relief segment is expected to register the highest growth during the forecast period. The dominance of anesthesia and pain relief applications in the medical nitrous oxide market is credited to their pivotal roles in both surgical and medical procedures. Nitrous oxide, celebrated for its anesthetic and analgesic properties, is widely embraced in healthcare settings due to its effectiveness in inducing conscious sedation and relieving pain during various medical interventions. This dominance is emphasized by the widespread use of nitrous oxide by healthcare professionals, as it offers swift and controllable sedation, significantly enhancing patient comfort and procedural success.
The hospital segment accounted for the largest share of the brain monitoring market in 2023.
The medical nitrous oxide market is classified by end user into hospitals, home healthcare, and academic and research institutions. As of 2023, the hospitals segment dominated the market. This is primarily due to the crucial role of nitrous oxide within hospital settings, particularly in the context of surgical and medical procedures. Hospitals, serving as central hubs for comprehensive healthcare services, extensively employ nitrous oxide for anesthesia and analgesia, offering a controlled and effective method for patient sedation during surgical interventions.
“North America to be the largest regional segment in the medical nitrous oxide market during the forecast period.”
Based on the region, the global medical nitrous oxide market is divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to hold the largest share of the market in 2023. The Asia Pacific region is anticipated to experience the most rapid growth during the forecast period. The significant expansion of the market in the Asia Pacific can be attributed to the dynamic growth in healthcare infrastructure, a rise in surgical procedures, and an increasing awareness of the advantages of nitrous oxide. These factors collectively contribute to an increased demand for medical nitrous oxide in the APAC region.
Breakdown of primaries
The break of primary participants was as mentioned below:
• By Company Type – Tier 1–35%, Tier 2–45%, and Tier 3–20%
• By Designation – C-level–35%, Director-level–25%, Others–40%
• By Region – North America–45%, Europe–30%, Asia Pacific–20%, Latin America- 3%, Middle East and Africa–2%
The medical nitrous oxide market is dominated by a few globally established players such as Carbide and Chemicals (India), nexAir (US), Air Liquide (Paris), Linde plc (Ireland), Southern Gas Limited (India), Jiangsu Huazhong Gas Co., Ltd. (China), American Welding & Gas (US), Oxygen & Argon Works Ltd (Israel), Matheson Tri-Gas Inc. (US), CalOx (US), Steelman Gases Pvt. Ltd. (India), Earlbeck Gases & Technology (US), Chengdu Taiyu Industrial Gases Co., Ltd. (China), Messer SE & CO. KGAA (Germany), SOL SpA (Italy), Ellenbarrie Industrial Gases (India), Norco Inc. (US), and Gulf Cryo (UAE).
Research Coverage:
The report segments the medical nitrous oxide market based on region (Asia Pacific, Europe, North America, Latin America, and Middle East & Africa), Product (gasesous, liquid), application (anesthesia and pain relief, cryosurgery, and surgical inflation), and end user(hospitals, home healthcare, and academic and research institutions).
The report also provides a comprehensive review of market drivers, restraints, and opportunities in the medical nitrous oxide market.
Key Benefits of Buying the Report:
The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the medical nitrous oxide market and provides them with information on key market drivers, restraints, challenges, and opportunities.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.
This report provides insights into the following pointers:
o Analysis of key drivers (growing aging population, advancements in healthcare infrastructure, demand for non-invasive methods for pain relief, and supportive regulations and standards regarding the use of medical gases), restraints (safery concerns, availability of alternatives, environmental concerns), opportunities (emerging markets, pediatric applications), challenges (limited awareness, economic factors).
o Market Penetration: Comprehensive information on product portfolios offered by the top players in the global medical nitrous oxide market. The report analyzes this market by products, application, and end users.
o Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global medical nitrous oxide market
o Market Development: Comprehensive information on the lucrative emerging markets by products, application, and end users.
o Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global medical nitrous oxide market
o Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players in the global medical nitrous oxide market.
Table of Contents
1 INTRODUCTION 29
1.1 STUDY OBJECTIVES 29
1.2 MARKET DEFINITION 29
1.2.1 INCLUSIONS AND EXCLUSIONS 29
1.3 MARKETS COVERED 30
FIGURE 1 MEDICAL NITROUS OXIDE MARKET SEGMENTATION 30
1.3.1 REGIONAL SEGMENTATION 30
1.3.2 YEARS CONSIDERED 31
1.3.3 CURRENCY CONSIDERED 31
1.4 STAKEHOLDERS 31
1.5 RECESSION IMPACT 31
2 RESEARCH METHODOLOGY 33
2.1 RESEARCH DATA 33
FIGURE 2 RESEARCH DESIGN 33
2.1.1 SECONDARY DATA 34
2.1.1.1 Key data from secondary sources 34
2.1.2 PRIMARY RESEARCH 35
2.1.2.1 Primary sources 36
2.1.2.2 Key data from primary sources 37
2.1.2.3 Key industry insights 37
2.1.2.4 Breakdown of primary interviews: by company type, designation, and region 38
2.2 MARKET SIZE ESTIMATION METHODOLOGY 38
FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 39
2.3 MARKET ESTIMATION 39
FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 40
FIGURE 5 MEDICAL NITROUS OXIDE MARKET: REVENUE SHARE ANALYSIS ILLUSTRATION FOR AIR LIQUIDE S.A. 40
FIGURE 6 MEDICAL NITROUS OXIDE MARKET: DEMAND-SIDE MODELING 41
FIGURE 7 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN MEDICAL NITROUS OXIDE MARKET (2023–2029) 42
FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 43
2.4 MARKET DATA ESTIMATION AND TRIANGULATION 44
FIGURE 9 DATA TRIANGULATION METHODOLOGY 44
2.5 STUDY ASSUMPTIONS 45
2.6 LIMITATIONS 45
2.6.1 SCOPE-RELATED LIMITATIONS 45
2.6.2 METHODOLOGY-RELATED LIMITATIONS 45
2.7 RISK ASSESSMENT 46
TABLE 1 RISK ASSESSMENT: MEDICAL NITROUS OXIDE MARKET 46
2.8 MEDICAL NITROUS OXIDE MARKET: RECESSION IMPACT 46
3 EXECUTIVE SUMMARY 47
FIGURE 10 MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2023 VS. 2029 (USD MILLION) 47
FIGURE 11 MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2023 VS. 2029 (USD MILLION) 48
FIGURE 12 MEDICAL NITROUS OXIDE MARKET, BY END USER, 2023 VS. 2029 (USD MILLION) 48
FIGURE 13 GEOGRAPHICAL SNAPSHOT OF MEDICAL NITROUS OXIDE MARKET 49
4 PREMIUM INSIGHTS 50
4.1 MEDICAL NITROUS OXIDE MARKET OVERVIEW 50
FIGURE 14 INCREASING NUMBER OF SURGERIES AND DENTAL PROCEDURES TO DRIVE MARKET GROWTH 50
4.2 NORTH AMERICA: MEDICAL NITROUS OXIDE MARKET, BY TYPE AND COUNTRY (2022) 51
FIGURE 15 LIQUID NITROUS OXIDE SEGMENT ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN MARKET IN 2022 51
4.3 MEDICAL NITROUS OXIDE MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 51
FIGURE 16 ASIA PACIFIC REGION TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 51
4.4 MEDICAL NITROUS OXIDE MARKET: REGIONAL MIX 52
FIGURE 17 ASIA PACIFIC MARKET TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 52
4.5 MEDICAL NITROUS OXIDE MARKET: DEVELOPED VS. EMERGING ECONOMIES 52
FIGURE 18 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD 52
5 MARKET OVERVIEW 53
5.1 INTRODUCTION 53
5.2 MARKET DYNAMICS 53
FIGURE 19 MEDICAL NITROUS OXIDE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 53
TABLE 2 MARKET DYNAMICS: IMPACT ANALYSIS 54
5.2.1 DRIVERS 54
5.2.1.1 Increasing number of surgeries and dental procedures 54
5.2.1.2 Growing adoption of nitrous oxide across various medical specialties 55
5.2.1.3 Rising geriatric population and subsequent increase in prevalence of chronic diseases 55
FIGURE 20 GLOBAL GERIATRIC POPULATION, BY REGION, 2010–2030 (% OF TOTAL POPULATION) 55
5.2.1.4 Growing demand for home healthcare 56
5.2.2 RESTRAINTS 56
5.2.2.1 Potential risks associated with nitrous oxide misuse 56
5.2.2.2 Availability of alternatives 56
5.2.3 OPPORTUNITIES 57
5.2.3.1 Rising demand for pain management 57
FIGURE 21 PREVALENCE OF CHRONIC PAIN AND HIGH-IMPACT CHRONIC PAIN AMONG ADULTS IN US, 2019–2021 57
5.2.3.2 Technological advancements 58
5.2.4 CHALLENGES 58
5.2.4.1 Changes in calibration standards 58
5.2.4.2 Lack of awareness 58
5.3 INDUSTRY TRENDS 59
5.3.1 ADVANCEMENTS IN NITROUS OXIDE DELIVERY SYSTEMS 59
5.3.2 GROWING DEMAND FOR MINIMALLY INVASIVE PROCEDURES 59
5.4 TECHNOLOGY ANALYSIS 60
5.4.1 KEY TECHNOLOGIES 60
5.4.1.1 Nitrous oxide delivery systems 60
5.4.1.2 Monitoring and control systems 60
5.4.1.3 Technological integration in anesthesia machines 60
5.4.2 COMPLEMENTARY TECHNOLOGIES 60
5.4.2.1 Patient monitoring devices 60
5.4.2.2 Smart devices and connectivity 60
5.4.3 ADJACENT TECHNOLOGIES 61
5.4.3.1 Advanced anesthetic agents 61
5.4.3.2 Surgical robotics 61
5.5 PRICING ANALYSIS 61
5.5.1 AVERAGE SELLING PRICE TREND OF MEDICAL NITROUS OXIDE, BY PRODUCT 61
TABLE 3 AVERAGE SELLING PRICE OF MEDICAL NITROUS OXIDE, BY PRODUCT TYPE (USD) 61
5.5.2 AVERAGE SELLING PRICE TREND, BY REGION 61
5.6 PORTER’S FIVE FORCES ANALYSIS 62
TABLE 4 PORTER’S FIVE FORCES ANALYSIS 62
5.6.1 INTENSITY OF COMPETITIVE RIVALRY 62
5.6.2 BARGAINING POWER OF SUPPLIERS 62
5.6.3 BARGAINING POWER OF BUYERS 62
5.6.4 THREAT OF SUBSTITUTES 62
5.6.5 THREAT OF NEW ENTRANTS 63
5.7 TARIFF & REGULATORY ANALYSIS 63
5.7.1 TARIFF FOR MEDICAL NITROUS OXIDE 63
5.7.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 63
5.7.3 NORTH AMERICA 63
5.7.3.1 US 63
TABLE 5 US: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 64
5.7.3.2 Canada 64
TABLE 6 CANADA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 65
5.7.4 EUROPE 65
TABLE 7 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS 66
5.7.5 ASIA PACIFIC 67
5.7.5.1 Japan 67
TABLE 8 JAPAN: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 67
5.7.5.2 China 67
TABLE 9 CHINA: STANDARDS FOR MEDICAL GAS EQUIPMENT 68
TABLE 10 CHINA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 68
5.7.5.3 India 69
TABLE 11 INDIA: STANDARDS FOR MEDICAL GAS EQUIPMENT 69
TABLE 12 INDIA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 69
5.7.6 LATIN AMERICA AND MIDDLE EAST & AFRICA 70
TABLE 13 LATIN AMERICA AND MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 70
5.8 VALUE CHAIN ANALYSIS 71
FIGURE 22 VALUE CHAIN ANALYSIS 71
5.9 ECOSYSTEM ANALYSIS 72
TABLE 14 MEDICAL NITROUS OXIDE MARKET: ECOSYSTEM MAPPING 72
FIGURE 23 MEDICAL NITROUS OXIDE MARKET: ECOSYSTEM 73
5.10 CASE STUDY ANALYSIS 73
5.10.1 CASE STUDY: EAST LANCASHIRE TEACHING HOSPITAL NHS FOUNDATION TRUST (ELHT) 73
5.11 PATENT ANALYSIS 74
5.11.1 PATENT PUBLICATION TRENDS 74
FIGURE 24 PATENT PUBLICATION TRENDS, 2014–2024 74
5.11.2 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR MEDICAL NITROUS OXIDE PATENTS (2014–2024) 75
TABLE 15 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR MEDICAL NITROUS OXIDE PATENTS 75
5.11.3 MEDICAL NITROUS OXIDE MARKET: TOP APPLICANTS 75
FIGURE 25 TOP APPLICANTS FOR MEDICAL NITROUS OXIDE PATENTS (2014–2024) 75
5.12 KEY STAKEHOLDERS & BUYING CRITERIA 76
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS 76
TABLE 16 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MEDICAL NITROUS OXIDE PRODUCTS 76
FIGURE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS 77
TABLE 17 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MEDICAL NITROUS OXIDE END USERS 77
5.12.2 BUYING CRITERIA 77
FIGURE 27 KEY BUYING CRITERIA FOR END USERS IN MEDICAL NITROUS OXIDE MARKET 77
TABLE 18 KEY BUYING CRITERIA FOR MEDICAL NITROUS OXIDE MARKET 78
5.13 KEY CONFERENCES & EVENTS IN 2024 78
TABLE 19 MEDICAL NITROUS OXIDE MARKET: DETAILED LIST OF CONFERENCES & EVENTS 78
5.14 TRADE ANALYSIS 79
5.14.1 TRADE ANALYSIS FOR MEDICAL NITROUS OXIDE 79
FIGURE 28 PRODUCT IMPORTS UNDER HSN CODE 281129, BY COUNTRY, 2022 (USD THOUSAND) 79
FIGURE 29 PRODUCT EXPORTS UNDER HSN CODE 281129, BY COUNTRY, 2022 (USD THOUSAND) 80
5.15 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 80
FIGURE 30 REVENUE SHIFT IN MEDICAL NITROUS OXIDE MARKET 80
5.16 UNMET NEEDS ANALYSIS 81
TABLE 20 UNMET NEEDS IN MEDICAL NITROUS OXIDE MARKET 81
5.16.1 END-USER EXPECTATIONS 82
TABLE 21 END-USER EXPECTATIONS IN MEDICAL NITROUS OXIDE MARKET 82
6 MEDICAL NITROUS OXIDE MARKET, BY TYPE 83
6.1 INTRODUCTION 84
TABLE 22 MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION) 84
TABLE 23 MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION) 84
6.2 LIQUID NITROUS OXIDE 84
6.2.1 RISING CRYOTHERAPY APPLICATIONS TO DRIVE MARKET 84
TABLE 24 LIQUID MEDICAL NITROUS OXIDE MARKET, BY COUNTRY, 2018–2021 (USD MILLION) 85
TABLE 25 LIQUID MEDICAL NITROUS OXIDE MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 86
6.3 GASEOUS NITROUS OXIDE 86
6.3.1 PRECISE DOSAGE CONTROL AND PORTABILITY TO DRIVE MARKET GROWTH 86
TABLE 26 GASEOUS MEDICAL NITROUS OXIDE MARKET, BY COUNTRY, 2018–2021 (USD MILLION) 87
TABLE 27 GASEOUS MEDICAL NITROUS OXIDE MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 88
7 MEDICAL NITROUS OXIDE MARKET, BY APPLICATION 89
7.1 INTRODUCTION 90
TABLE 28 MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION) 90
TABLE 29 MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 90
7.2 ANESTHESIA & PAIN RELIEF 90
7.2.1 WIDE USAGE AS CARRIER FOR OTHER ANESTHETIC GASES TO DRIVE MARKET 90
TABLE 30 MEDICAL NITROUS OXIDE MARKET FOR ANESTHESIA & PAIN RELIEF, BY COUNTRY, 2018–2021 (USD MILLION) 91
TABLE 31 MEDICAL NITROUS OXIDE MARKET FOR ANESTHESIA & PAIN RELIEF, BY COUNTRY, 2022–2029 (USD MILLION) 92
7.3 CRYOSURGERY 92
7.3.1 PAINLESSNESS OF CRYOSURGICAL PROCEDURES TO SUPPORT ADOPTION 92
TABLE 32 MEDICAL NITROUS OXIDE MARKET FOR CRYOSURGERY, BY COUNTRY, 2018–2021 (USD MILLION) 93
TABLE 33 MEDICAL NITROUS OXIDE MARKET FOR CRYOSURGERY, BY COUNTRY, 2022–2029 (USD MILLION) 94
7.4 SURGICAL INSUFFLATION 94
7.4.1 USE OF NITROUS OXIDE AS INSUFFLATION GAS IN LAPAROSCOPIC AND ENDOSCOPIC SURGERIES TO DRIVE MARKET 94
TABLE 34 MEDICAL NITROUS OXIDE MARKET FOR SURGICAL INSUFFLATION, BY COUNTRY, 2018–2021 (USD MILLION) 95
TABLE 35 MEDICAL NITROUS OXIDE MARKET FOR SURGICAL INSUFFLATION, BY COUNTRY, 2022–2029 (USD MILLION) 96
8 MEDICAL NITROUS OXIDE MARKET, BY END USER 97
8.1 INTRODUCTION 98
TABLE 36 MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION) 98
TABLE 37 MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION) 98
8.2 HOSPITALS 98
8.2.1 EXTENSIVE USAGE OF MEDICAL NITROUS OXIDE TO DRIVE MARKET 98
TABLE 38 MEDICAL NITROUS OXIDE MARKET FOR HOSPITALS, BY COUNTRY, 2018–2021 (USD MILLION) 99
TABLE 39 MEDICAL NITROUS OXIDE MARKET FOR HOSPITALS, BY COUNTRY, 2022–2029 (USD MILLION) 100
8.3 HOME CARE SETTINGS 100
8.3.1 HOME CARE SETTINGS TO WITNESS HIGHEST GROWTH DUE TO RISING PREVALENCE OF CHRONIC DISEASES 100
TABLE 40 MEDICAL NITROUS OXIDE MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2018–2021 (USD MILLION) 101
TABLE 41 MEDICAL NITROUS OXIDE MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2022–2029 (USD MILLION) 102
8.4 ACADEMIC & RESEARCH INSTITUTES 102
8.4.1 COLLABORATION WITH INDUSTRY PARTNERS FOR TECHNOLOGICAL ADVANCES TO SUPPORT GROWTH 102
TABLE 42 MEDICAL NITROUS OXIDE MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018–2021 (USD MILLION) 103
TABLE 43 MEDICAL NITROUS OXIDE MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 104
9 MEDICAL NITROUS OXIDE MARKET, BY REGION 105
9.1 INTRODUCTION 106
TABLE 44 MEDICAL NITROUS OXIDE MARKET, BY REGION, 2018–2021 (USD MILLION) 106
TABLE 45 MEDICAL NITROUS OXIDE MARKET, BY REGION, 2022–2029 (USD MILLION) 106
9.2 NORTH AMERICA 107
9.2.1 NORTH AMERICA: RECESSION IMPACT 107
FIGURE 31 NORTH AMERICA: MEDICAL NITROUS OXIDE MARKET SNAPSHOT 108
TABLE 46 NORTH AMERICA: MEDICAL NITROUS OXIDE MARKET, BY COUNTRY, 2018–2021 (USD MILLION) 109
TABLE 47 NORTH AMERICA: MEDICAL NITROUS OXIDE MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 109
TABLE 48 NORTH AMERICA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION) 109
TABLE 49 NORTH AMERICA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION) 110
TABLE 50 NORTH AMERICA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION) 110
TABLE 51 NORTH AMERICA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 110
TABLE 52 NORTH AMERICA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION) 111
TABLE 53 NORTH AMERICA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION) 111
9.2.2 US 111
9.2.2.1 US to dominate North American medical nitrous oxide market 111
TABLE 54 US: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION) 112
TABLE 55 US: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION) 112
TABLE 56 US: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION) 112
TABLE 57 US: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 113
TABLE 58 US: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION) 113
TABLE 59 US: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION) 113
9.2.3 CANADA 114
9.2.3.1 Stringent regulatory compliance to support market growth in Canada 114
TABLE 60 CANADA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION) 114
TABLE 61 CANADA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION) 114
TABLE 62 CANADA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION) 115
TABLE 63 CANADA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 115
TABLE 64 CANADA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION) 115
TABLE 65 CANADA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION) 116
9.3 EUROPE 116
9.3.1 EUROPE: RECESSION IMPACT 116
TABLE 66 EUROPE: MEDICAL NITROUS OXIDE MARKET, BY COUNTRY, 2018–2021 (USD MILLION) 117
TABLE 67 EUROPE: MEDICAL NITROUS OXIDE MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 117
TABLE 68 EUROPE: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION) 117
TABLE 69 EUROPE: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION) 118
TABLE 70 EUROPE: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION) 118
TABLE 71 EUROPE: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 118
TABLE 72 EUROPE: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION) 119
TABLE 73 EUROPE: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION) 119
9.3.2 GERMANY 119
9.3.2.1 Increasing healthcare spending to drive market 119
TABLE 74 GERMANY: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION) 120
TABLE 75 GERMANY: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION) 120
TABLE 76 GERMANY: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION) 120
TABLE 77 GERMANY: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 121
TABLE 78 GERMANY: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION) 121
TABLE 79 GERMANY: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION) 121
9.3.3 UK 122
9.3.3.1 Increasing surgeries & dental procedures to drive market 122
TABLE 80 UK: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION) 122
TABLE 81 UK: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION) 122
TABLE 82 UK: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION) 123
TABLE 83 UK: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 123
TABLE 84 UK: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION) 123
TABLE 85 UK: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION) 124
9.3.4 FRANCE 124
9.3.4.1 Well-established healthcare system to drive market 124
TABLE 86 FRANCE: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION) 124
TABLE 87 FRANCE: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION) 125
TABLE 88 FRANCE: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION) 125
TABLE 89 FRANCE: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 125
TABLE 90 FRANCE: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION) 126
TABLE 91 FRANCE: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION) 126
9.3.5 ITALY 126
9.3.5.1 Rapid growth in geriatric population and rising life expectancy to favor market growth 126
TABLE 92 ITALY: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION) 127
TABLE 93 ITALY: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION) 127
TABLE 94 ITALY: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION) 127
TABLE 95 ITALY: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 128
TABLE 96 ITALY: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION) 128
TABLE 97 ITALY: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION) 128
9.3.6 SPAIN 129
9.3.6.1 Increasing prevalence of cancer to support market growth 129
TABLE 98 SPAIN: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION) 129
TABLE 99 SPAIN: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION) 129
TABLE 100 SPAIN: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION) 129
TABLE 101 SPAIN: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 130
TABLE 102 SPAIN: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION) 130
TABLE 103 SPAIN: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION) 130
9.3.7 REST OF EUROPE 131
TABLE 104 REST OF EUROPE: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION) 131
TABLE 105 REST OF EUROPE: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION) 131
TABLE 106 REST OF EUROPE: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION) 132
TABLE 107 REST OF EUROPE: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 132
TABLE 108 REST OF EUROPE: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION) 132
TABLE 109 REST OF EUROPE: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION) 133
9.4 ASIA PACIFIC 133
9.4.1 ASIA PACIFIC: RECESSION IMPACT 133
FIGURE 32 ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET SNAPSHOT 134
TABLE 110 ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY COUNTRY, 2018–2021 (USD MILLION) 135
TABLE 111 ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 135
TABLE 112 ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION) 135
TABLE 113 ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION) 136
TABLE 114 ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION) 136
TABLE 115 ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 136
TABLE 116 ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION) 137
TABLE 117 ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION) 137
9.4.2 JAPAN 137
9.4.2.1 Japan to hold largest share of APAC market 137
TABLE 118 JAPAN: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION) 138
TABLE 119 JAPAN: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION) 138
TABLE 120 JAPAN: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION) 138
TABLE 121 JAPAN: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 139
TABLE 122 JAPAN: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION) 139
TABLE 123 JAPAN: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION) 139
9.4.3 CHINA 140
9.4.3.1 Strong investments in infrastructural development to offer opportunities for market growth 140
TABLE 124 CHINA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION) 140
TABLE 125 CHINA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION) 140
TABLE 126 CHINA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION) 141
TABLE 127 CHINA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 141
TABLE 128 CHINA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION) 141
TABLE 129 CHINA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION) 142
9.4.4 INDIA 142
9.4.4.1 Rising procedural volume to ensure sustained demand for medical gases 142
TABLE 130 INDIA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION) 142
TABLE 131 INDIA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION) 143
TABLE 132 INDIA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION) 143
TABLE 133 INDIA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 143
TABLE 134 INDIA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION) 144
TABLE 135 INDIA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION) 144
9.4.5 REST OF ASIA PACIFIC 144
TABLE 136 REST OF ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION) 144
TABLE 137 REST OF ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION) 145
TABLE 138 REST OF ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION) 145
TABLE 139 REST OF ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 145
TABLE 140 REST OF ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION) 146
TABLE 141 REST OF ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION) 146
9.5 LATIN AMERICA 146
9.5.1 RISING PUBLIC-PRIVATE PARTNERSHIPS FOR HEALTHCARE DEVELOPMENT TO PROMOTE ADOPTION OF MEDICAL NITROUS OXIDE 146
9.5.2 LATIN AMERICA: RECESSION IMPACT 147
TABLE 142 LATIN AMERICA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION) 147
TABLE 143 LATIN AMERICA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION) 147
TABLE 144 LATIN AMERICA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION) 147
TABLE 145 LATIN AMERICA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 148
TABLE 146 LATIN AMERICA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION) 148
TABLE 147 LATIN AMERICA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION) 148
9.6 MIDDLE EAST & AFRICA 149
9.6.1 GOVERNMENT INITIATIVES FOR INFRASTRUCTURAL DEVELOPMENT TO SUPPORT MARKET GROWTH 149
9.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT 149
TABLE 148 MIDDLE EAST & AFRICA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION) 149
TABLE 149 MIDDLE EAST & AFRICA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION) 150
TABLE 150 MIDDLE EAST & AFRICA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION) 150
TABLE 151 MIDDLE EAST & AFRICA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 150
TABLE 152 MIDDLE EAST & AFRICA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION) 151
TABLE 153 MIDDLE EAST & AFRICA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION) 151
10 COMPETITIVE LANDSCAPE 152
10.1 OVERVIEW 152
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 152
TABLE 154 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN MEDICAL NITROUS OXIDE MARKET 153
10.3 REVENUE ANALYSIS 154
FIGURE 33 REVENUE ANALYSIS OF KEY PLAYERS IN MEDICAL NITROUS OXIDE MARKET, 2018–2022 (USD MILLION) 154
10.4 MARKET SHARE ANALYSIS 154
FIGURE 34 MEDICAL NITROUS OXIDE MARKET SHARE ANALYSIS (2022) 155
TABLE 155 MEDICAL NITROUS OXIDE MARKET: DEGREE OF COMPETITION 155
10.5 MARKET RANKING ANALYSIS 156
FIGURE 35 MEDICAL NITROUS OXIDE MARKET RANKING, BY KEY PLAYER, 2022 156
10.6 COMPANY EVALUATION MATRIX: KEY PLAYERS 157
10.6.1 STARS 157
10.6.2 EMERGING LEADERS 157
10.6.3 PERVASIVE PLAYERS 158
10.6.4 PARTICIPANTS 158
FIGURE 36 MEDICAL NITROUS OXIDE MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023 158
10.6.5 COMPANY FOOTPRINT 159
FIGURE 37 MEDICAL NITROUS OXIDE MARKET: COMPANY FOOTPRINT 159
TABLE 156 MEDICAL NITROUS OXIDE MARKET: TYPE FOOTPRINT 160
TABLE 157 MEDICAL NITROUS OXIDE MARKET: APPLICATION FOOTPRINT 161
TABLE 158 MEDICAL NITROUS OXIDE MARKET: END-USER FOOTPRINT 162
TABLE 159 MEDICAL NITROUS OXIDE MARKET: REGIONAL FOOTPRINT 163
10.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES 164
10.7.1 PROGRESSIVE COMPANIES 164
10.7.2 RESPONSIVE COMPANIES 164
10.7.3 DYNAMIC COMPANIES 164
10.7.4 STARTING BLOCKS 164
FIGURE 38 MEDICAL NITROUS OXIDE MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 165
10.7.5 COMPETITIVE BENCHMARKING 166
10.7.5.1 Detailed list of key startups/SMEs 166
TABLE 160 MEDICAL NITROUS OXIDE: DETAILED LIST OF KEY STARTUPS/SMES 166
10.7.5.2 Competitive benchmarking of key startups/SMEs 167
TABLE 161 MEDICAL NITROUS OXIDE: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 167
10.8 BRAND/PRODUCT COMPARISON 168
10.9 COMPANY EVALUATION AND FINANCIAL METRICS 169
FIGURE 39 EV/EBITDA OF KEY VENDORS 169
FIGURE 40 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF MEDICAL NITROUS OXIDE VENDORS 169
10.10 COMPETITIVE SCENARIO 170
10.10.1 DEALS 170
TABLE 162 MEDICAL NITROUS OXIDE MARKET: DEALS, JANUARY 2020– JANUARY 2024 170
10.10.2 EXPANSIONS 171
TABLE 163 MEDICAL NITROUS OXIDE MARKET: EXPANSIONS, JANUARY 2020–JANUARY 2024 171
11 COMPANY PROFILES 172
11.1 KEY PLAYERS 172
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
11.1.1 AIR LIQUIDE 172
TABLE 164 AIR LIQUIDE: COMPANY OVERVIEW 172
FIGURE 41 AIR LIQUIDE: COMPANY SNAPSHOT (2022) 173
11.1.2 LINDE PLC 175
TABLE 165 LINDE PLC: COMPANY OVERVIEW 175
FIGURE 42 LINDE PLC: COMPANY SNAPSHOT (2022) 176
11.1.3 SOL SPA 178
TABLE 166 SOL SPA: COMPANY OVERVIEW 178
FIGURE 43 SOL SPA: COMPANY SNAPSHOT (2022) 179
11.1.4 TAIYO NIPPON SANSO CORPORATION 181
TABLE 167 TAIYO NIPPON SANSO CORPORATION: COMPANY OVERVIEW 181
FIGURE 44 TAIYO NIPPON SANSO CORPORATION: COMPANY SNAPSHOT (2023) 182
11.1.5 NORCO INC. 184
TABLE 168 NORCO INC.: COMPANY OVERVIEW 184
11.1.6 SOUTHERN GAS LIMITED 186
TABLE 169 SOUTHERN GAS LIMITED: COMPANY OVERVIEW 186
FIGURE 45 SOUTHERN GAS LIMITED: COMPANY SNAPSHOT (2022) 186
11.1.7 ELLENBARRIE INDUSTRIAL GASES 187
TABLE 170 ELLENBARRIE INDUSTRIAL GASES: COMPANY OVERVIEW 187
FIGURE 46 ELLENBARRIE INDUSTRIAL GASES: COMPANY SNAPSHOT (2020) 187
11.1.8 CALOX INC. 188
TABLE 171 CALOX INC.: COMPANY OVERVIEW 188
11.1.9 STEELMAN GASES PVT. LTD. 189
TABLE 172 STEELMAN GASES PVT. LTD.: COMPANY OVERVIEW 189
11.1.10 NEXAIR 190
TABLE 173 NEXAIR: COMPANY OVERVIEW 190
11.1.11 OXYGEN & ARGON WORKS LTD. 192
TABLE 174 OXYGEN & ARGON WORKS LTD.: COMPANY OVERVIEW 192
11.1.12 GULFCRYO 193
TABLE 175 GULFCRYO: COMPANY OVERVIEW 193
11.1.13 CHENGDU TAIYO INDUSTRIAL GASES CO., LTD. 194
TABLE 176 CHENGDU TAIYO INDUSTRIAL GASES CO. LTD.: COMPANY OVERVIEW 194
11.1.14 JIANGSU HUAZHONG GAS CO., LTD. 195
TABLE 177 JIANGSU HAUZHONG GAS CO., LTD.: COMPANY OVERVIEW 195
11.1.15 CARBIDE AND CHEMICALS 196
TABLE 178 CARBIDE AND CHEMICALS: COMPANY OVERVIEW 196
11.1.16 AMERICAN WELDING & GAS 197
TABLE 179 AMERICAN WELDING & GAS: COMPANY OVERVIEW 197
11.1.17 ASIA INDUSTRIAL GASES PTE. LTD. 198
TABLE 180 ASIA INDUSTRIAL GASES PTE. LTD.: COMPANY OVERVIEW 198
11.1.18 MIDDLESEX GASES & TECHNOLOGY INC. 199
TABLE 181 MIDDLESEX GASES & TECHNOLOGIES INC.: COMPANY OVERVIEW 199
11.1.19 AMERITANX CYLINDERS 200
TABLE 182 AMERITANX CYLINDERS: COMPANY OVERVIEW 200
11.1.20 CRYOCARB 201
TABLE 183 CRYOCARB: COMPANY OVERVIEW 201
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
11.2 OTHER PLAYERS 202
11.2.1 HOLSTON GASES 202
11.2.2 AOPL 202
11.2.3 BUTLER GAS PRODUCTS COMPANY 203
11.2.4 GRUPPO SIAD 203
11.2.5 ANDY OXY CO., INC. 203
12 APPENDIX 204
12.1 DISCUSSION GUIDE 204
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 206
12.3 CUSTOMIZATION OPTIONS 208
12.4 RELATED REPORTS 208
12.5 AUTHOR DETAILS 209